Search

Search Constraints

You searched for: Author/Creator Salphati, Laurent

Search Results

1. Absorption, metabolism and excretion of pictilisib, a potent pan-class I phosphatidylinositol-3-Kinase (PI3K) inhibitor, in rats, dogs, and humans. (3rd July 2021)

2. Absorption, metabolism, and excretion of taselisib (GDC-0032), a PI3K inhibitor, in rats, dogs, and humans. Issue 1 (January 2017)

3. Can transporter-expressing cells predict rosuvastatin uptake clearance in suspended or plated human hepatocytes?. Issue 1 (January 2019)

4. Combining "Bottom‐up" and "Top‐down" Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics. (17th October 2017)

7. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma. Issue 16 (15th August 2019)

8. Determination of GDC‐0980 (apitolisib), a small molecule dual phosphatidylinositide 3‐kinase/mammalian target of rapamycin inhibitor in dog plasma by LC‐MS/MS to support a GLP toxicology study. (10th February 2015)

9. Does plasma membrane and total transporter abundance differ between suspended, plated, sandwich culture hepatocytes and human liver tissue?. Issue 1 (January 2019)